1. Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk- stratification, and management. Am J Hematol 2016; 91:151-65.
2. LeBoit PE, Burg G, Weedon D, Sarasain A. (eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. IARC Press: Lyon 2006.p.164-199.
3. Riou-Gotta MO, Fournier E, Mermet I,
Pelletier F, Humbert P, Danzon A, et al.
Primary cutaneous lymphomas: a
population-based descriptive study of 71
consecutive cases diagnosed between 1980 and 2003. Leuk Lymphoma 2008 49: 1537- 44. Available at: doi: 10.080/10428190802136368. Last viewed on June 10th , 2016.
4. Horwitz SM. Fast Facts: Primary Cutaneous B-Cell Lymphoma. Available at: http://www.clfoundation.org/sites/default/f iles/publications/CLF_CBCL_Fast_Facts.pdf . Last viewed on July 1st , 2014.
5. Cardona DM, Layne A, Lagoo AS. Lymphomas of the gastro-intestinal tract - Pathophysiology, pathology, and differential diagnosis. Indian J Pathol Microbiol 55(1):1- 16 Available from: http://wwwijpmonlineorg/textasp?2012/55 /1/1/94847 Last viewed on July 1st , 2014.
6. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population- based study of 3884 cases. Blood 2009; 113 5064-73. Available at: doi: 10.1182/blood- 2008-10-184168. Last viewed on June 4th , 2016.
7. Weedon D. Cutaneous infiltrates – lymphoid and leukaemic. In: Weedon D, editor. Weedon Skin Pathology, 3rd ed. China: Churchill Livingstone Elsevier; 2010.p.902-917
8. Asuquo ME, Ebughe G. Cutaneous cancers in Calabar, Southern Nigeria. Dermatology Online Journal 2009; 15: Available at: http://anagen.ucdavis.edu/1504/case_pres entations/cutaneous_cancer/asuquo.html. Last viewed on October 12 , 2013.
9. Datubo-Brown DD. Primary malignant skin tumors in Nigerians. J Natl Med Assoc 1991; 83(4):345-358.
10. Forae GD, Olu-Eddo AN. Malignant Skin Tumors in Benin City, South-South, Nigeria. Oman Medical Journal 2013; 28(5):311-315.
11. Gana JY, Ademola SA. Skin malignancies in Ibadan: a comparative study. NJPS 2008; 4(1):1-6.
12. Mandong BM, Orkar KS, Sule AZ, Dakun NL. Malignant Skin Tumours in Jos University Teaching Hospital, Jos, Nigeria (Hospital Based Study). Nig J Surg Res 2001; 3(1):29-33.
13. Nnabuko RE, Otene CI, Otei OO, Okwesili CI. Pattern of Skin cancer at the National Orthopaedic Hospital, Enugu. NJPS 2008; 4(1):13-18.
14. Samaila MOA, Adewuyi SA. A
histopathological analysis of cutaneous malignancies in a tropical African population. Nig J Surg Res 2005; 7(3-4):300- 304.
15. Adu EJ, Annan C. Primary malignant skin tumours in Ghanaians: a prospective study of 31 cases. NJPS. 2008; 4(1): 7-13.
16. Adeyi O, Banjo A. Malignant Tumours of The Skin: A 6-Year Review of Histologically Diagnosed Cases (1990-1995). Nig Qt J Hosp Med 1998; 8(2): 99-102.
17. Assaf C, Gellrich S, Steinhoff M, Nashan D, Weisse F, Dippel E, et al. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology. J Dtsch Dermatol Ges 2007; 5: 662–8.
18. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007; 143: 854–9.
19. Reddy VB. Skin and adnexal structures. In: Gattuso P, editor. Differential diagnosis in surgical pathology. Philadelphia: Saunders
Elseviers; 2010.p.118-120.
20. Sokol L, Mojdeh Naghashpour M, Frank
Glass FL. Primary Cutaneous B-Cell Lymphomas: Recent Advances in Diagnosis and Management. Cancer Control 2012; 19(3): 236-44.
21. Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, et al. Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 2006; 24 (9): 1376-82.
22. Aguilera NSI, Tomaszewski MM, Moad JC, Bauer FA, Taubenberger JK, Abbondanzo SL. Cutaneous Follicle Center Lymphoma: A Clinicopathologic Study of 19 Cases. Mod Pathol 2001; 14: 828–35.
23. Vermeer MH, Geelen FAMJ, van Haselen CW, van Voorst Vader PC, Geerts ML, van Vloten WA, et al. Primary cutaneous large B- cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol 1996; 132(11): 1304-8.